In general, pay for these top execs skyrocketed 1,460% from 1978 to 2021, according to data from the Economic Policy Institute. And even when they don’t technically take a high base salary, CEOs frequently bring home tens of millions through stock options, biotech execs included.
According to a ranking from CEO World Magazine, the U.S.’s 23 highest-paid biopharma CEOs brought home salaries in 2022 ranging from $124.9 million to $18.5 million. A quick scan of the names on this list reveals two Davids, two Roberts and two Daniels — but just three women.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,